共 43 条
- [41] CAN USE OF HIGH COST DRUGS FOR RARE RHEUMATIC DISEASES BE RELIABLY IDENTIFIED WITHIN ROUTINELY COLLECTED NHS DATA? RESULTS FROM A PILOT STUDY OF RITUXIMAB USE IN VASCULITIS USING DATA FROM THE NATIONAL DISEASE REGISTRATION SERVICE (NDRS) AND THE REGISTRATION OF COMPLEX RARE DISEASES - EXEMPLARS IN RHEUMATOLOGY (RECORDER) PROJECT RHEUMATOLOGY, 2021, 60
- [43] P091 Can use of high cost drugs for rare rheumatic diseases be reliably identified within routinely collected NHS data? Results from a pilot study of rituximab use in vasculitis using data from the National Disease Registration Service (NDRS) and the Registration of Complex Rare Diseases-Exemplars in Rheumatology (RECORDER) project RHEUMATOLOGY, 2021, 60